Eisai at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Eisai takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 8067. Its program centres on kidney cancer and the choice of first-line treatment. It looks at how the treatment landscape for renal cell carcinoma keeps changing.

OrganizationESMO 2026 Attendance
Eisai
Tokyo, Japan
eisai.com
Large pharmaExhibitor
Japanese pharmaceutical company whose oncology medicines include lenvatinib and eribulin.
Booth
Exhibiting at Booth 8067
Satellite
Fri Oct 23
09:45–11:15
Eisai - RCC in Motion: First-Line Choice and the Evolving RCC Treatment Landscape
Sponsored session · with Vanderbilt-Ingram Cancer Center
Genitourinary cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Eisai

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction